A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma

Medical Science Monitor

Volumn 18, Issue 5, 2012, Pages

  Lv, Sheng Qing ^a   Song, Ye Chun ^a   Xu, Jian Ping ^a   Shu, Hai Feng ^a   Zhou, Zheng ^a   An, Ning ^a   Huang, Qi Lin ^a   Yang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Choroid plexus carcinoma (CPC); Immunohistochemical stain (IHC); Somatic mutation; TP53

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; EOSIN; GADOLINIUM PENTETATE; HEMATOXYLIN; KI 67 ANTIGEN; PARAFFIN; PREALBUMIN; PROTEIN P53; PROTEIN S 100; VIMENTIN;

ARTICLE; BABINSKI REFLEX; BODY TEMPERATURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN NECROSIS; BRAIN TISSUE; BRAIN VENTRICLE DILATATION; CANCER SURGERY; CANCER TISSUE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; CHOROID PLEXUS TUMOR; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; DNA SEQUENCE; FEMALE; FEVER; GAMMA KNIFE RADIOSURGERY; HEAD CIRCUMFERENCE; HEADACHE; HEMIPARESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; LATERAL BRAIN VENTRICLE; LIMB WEAKNESS; MICROSURGERY; MUSCLE STRENGTH; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; PAPILLEDEMA; PATHOGENESIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RADIATION DOSE; REOPERATION; RHINORRHEA; SOMATIC MUTATION; TUMOR BLEEDING; TUMOR RECURRENCE; VOMITING; WALKING DIFFICULTY; WEIGHT REDUCTION;

EID: 84860688921     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882720     Document Type: Article

References (24)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenne WK (eds.): WHO Classification of Tumours of the Central Nervous System. Lyon, IARC Press, 2007
2. Cohen ME, PK D (eds.): Brain tumors in children: principles of diagnosis and treatment. 2nd ed. New York, Raven, 1994
3. Packer RJ, Perilongo G, Johnson D et al: Choroid plexus carcinoma of childhood. Cancer, 1992; 69: 580-85
4. Gopal P, Parker JR, Debski R, Parker JC Jr: Choroid plexus carcinoma. Arch Pathol Lab Med, 2008; 132: 1350-54
5. Becherini F, Castagna M, Iannelli A et al: Choroid plexus carcinoma: a new case associated with a novel TP53 germ line mutation. Neuropathol Appl Neurobiol, 2008; 34: 564-68
6. Vital A, Bringuier PP, Huang H et al: Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropath Exp Neurol, 1998; 57: 1061-69
7. Hayat MA (ed.): Handbook of immunohistochemistry and in situ hybridization of human carcinomas, Vol. 4. San Diego, Elsevier Academic Press, 2006
8. Ohgaki H, Dessen P, Jourde B et al: Genetic pathways to glioblastoma: a population-based study. Cancer Res, 2004; 64: 6892-99
9. Baehring JM, Duncan C, Ogle E, Kim J: Images in neuro-oncology: choroid plexus carcinoma. J Neuro-oncol, 2006; 79: 31-32
10. Judkins AR, Burger PC, Hamilton RL et al: INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropath Exp Neurol, 2005; 64: 391-97
11. Jeibmann A, Hasselblatt M, Gerss J et al: Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropath Exp Neurol, 2006; 65: 1069-73
12. Paulus W, Janisch W: Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases. Acta Neuropathol, 1990; 80: 635-41
13. Carlotti CG Jr, Salhia B, Weitzman S et al: Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children. Acta Neuropathol, 2002; 103: 1-10
14. Kumabe T, Fujimura M, Jokura H, Tominaga T: Surgical treatment for choroid plexus tumors in the fourth ventricle: brain stem infiltration hinders total extirpation. Neurosurg Rev, 2008; 31: 165-72; discussion 172
15. Berger C, Thiesse P, Lellouch-Tubiana A et al: Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery, 1998; 42: 470-75
16. Wrede B, Liu P, Wolff JE: Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neuro-oncol, 2007; 85: 345-51
17. Mazloom A, Wolff JE, Paulino AC: The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiation Oncology Biol Phys, 2010; 78: 79-84
18. Kim IY, Niranjan A, Kondziolka D et al: Gamma knife radiosurgery for treatment resistant choroid plexus papillomas. J Neuro-oncol, 2008; 90: 105-10
19. Olivier M, Hollstein M, Hainaut P: TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol, 2010; 2: a001008
20. Krutilkova V, Trkova M, Fleitz J et al: Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer, 2005; 41: 1597-603
21. Schniederjan MJ, Shehata B, Brat DJ et al: De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. Pediatr Blood Cancer, 2009; 53: 1352-54
22. Russell-Swetek A, West AN, Mintern JE et al: Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma. J Med Gene, 2008; 45: 603-6
23. Tabori U, Shlien A, Baskin B et al: TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Onco, 2010; 28: 1995-2001
24. Zakrzewska M, Wojcik I, Zakrzewski K et al: Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas. Cancer Genet Cytogen, 2005; 156: 179-82